Andre Schulten
Insider (Form 4 reporting owner): Chief Financial Officer CIK 1844763Name as filed: Schulten AndreIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 1 Apr 2021, sold $33.2M in 21 sales of Procter & Gamble.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| Procter & Gamble PG | Chief Financial Officer | 1 Apr 2021 | 5 Nov 2026 | – | 21$33.2M |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After sales | -1.3 pts15 trades, 40% above the sector | -0.0 pts15 trades, 47% above the sector | -5.3 pts15 trades, 27% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2026 | – | – | 4 | $12.1M | -$12.1M |
| 2025 | – | – | 3 | $2.5M | -$2.5M |
| 2024 | – | – | 3 | $4.0M | -$4.0M |
| 2023 | – | – | 5 | $10.5M | -$10.5M |
| 2022 | – | – | 2 | $352K | -$352K |
| 2021 | – | – | 4 | $3.8M | -$3.8M |
Every trade
21, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 5 Nov 2026 | Procter & Gamble PG | Sellafter exercising options | 30,677 | $169.00 | $5.2M | No | Form 4filed 9 Nov 2026 |
| 4 Nov 2026 | Procter & Gamble PG | Sellafter exercising options | 33,624 | $165.00 | $5.5M | No | Form 4filed 5 Nov 2026 |
| 5 Oct 2026 | Procter & Gamble PG | Sell | 3,914 | $145.34 | $569K | No | Form 4filed 6 Oct 2026 |
| 20 Aug 2026 | Procter & Gamble PG | Sell | 5,402 | $143.79 | $777K | No | Form 4filed 24 Aug 2026 |
| 10 Nov 2025 | Procter & Gamble PG | Sell | 1 | $146.37 | $190 | No | Form 4filed 12 Nov 2025 |
| 2 Oct 2025 | Procter & Gamble PG | Sell | 4,252 | $152.23 | $647K | No | Form 4filed 6 Oct 2025 |
| 19 Aug 2025 | Procter & Gamble PG | Sell | 11,638 | $157.27 | $1.8M | No | Form 4filed 20 Aug 2025 |
| 2 Oct 2024 | Procter & Gamble PG | Sell | 1,569 | $171.65 | $269K | No | Form 4filed 3 Oct 2024 |
| 26 Aug 2024 | Procter & Gamble PG | Sell | 13,041 | $170.00 | $2.2M | No | Form 4filed 27 Aug 2024 |
| 20 Aug 2024 | Procter & Gamble PG | Sell | 9,150 | $169.22 | $1.5M | No | Form 4filed 22 Aug 2024 |
| 6 Nov 2023 | Procter & Gamble PG | Sellafter exercising options | 40,298 | $150.61 | $6.1M | No | Form 4filed 7 Nov 2023 |
| 2 Oct 2023 | Procter & Gamble PG | Sell | 1,599 | $144.97 | $232K | No | Form 4filed 3 Oct 2023 |
| 17 Aug 2023 | Procter & Gamble PG | Sell | 806 | $152.85 | $123K | No | Form 4filed 18 Aug 2023 |
| 24 Apr 2023 | Procter & Gamble PG | Sellafter exercising options | 25,244 | $155.27 | $3.9M | No | Form 4filed 25 Apr 2023 |
| 1 Mar 2023 | Procter & Gamble PG | Sell | 1,311 | $137.34 | $180K | Not stated | Form 4filed 2 Mar 2023 |
| 17 Aug 2022 | Procter & Gamble PG | Sell | 987 | $149.33 | $147K | Not stated | Form 4filed 18 Aug 2022 |
| 1 Mar 2022 | Procter & Gamble PG | Sell | 1,335 | $153.51 | $205K | Not stated | Form 4filed 3 Mar 2022 |
| 23 Aug 2021 | Procter & Gamble PG | Sell | 1,513 | $144.50 | $219K | Not stated | Form 4filed 23 Aug 2021 |
| 17 Aug 2021 | Procter & Gamble PG | Sell | 1,010 | $144.37 | $146K | Not stated | Form 4filed 19 Aug 2021 |
| 12 May 2021 | Procter & Gamble PG | Sellafter exercising options | 24,410 | $136.44 | $3.3M | Not stated | Form 4filed 13 May 2021 |
| 1 Apr 2021 | Procter & Gamble PG | Sell | 571 | $133.53 | $76K | Not stated | Form 4filed 1 Apr 2021 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.